- search hit 1 of 1
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Please always quote using this URN: urn:nbn:de:bvb:20-opus-110617
- Background Peptide receptor radionuclide therapy (PRRT) is routinely used for advanced or metastasized neuroendocrine tumours (NET). To prevent nephrotoxicity, positively charged amino acids (AA) are co-infused. The aim of this study was to correlate the risk for therapy-related hyperkalaemia with the total amount of AA infused. Methods Twenty-two patients undergoing PRRT with standard activities of 177Lu-DOTATATE/-TOC were monitored during two following treatment cycles with co-infusion of 75 and 50 g of AA (L-arginine and L-lysine),Background Peptide receptor radionuclide therapy (PRRT) is routinely used for advanced or metastasized neuroendocrine tumours (NET). To prevent nephrotoxicity, positively charged amino acids (AA) are co-infused. The aim of this study was to correlate the risk for therapy-related hyperkalaemia with the total amount of AA infused. Methods Twenty-two patients undergoing PRRT with standard activities of 177Lu-DOTATATE/-TOC were monitored during two following treatment cycles with co-infusion of 75 and 50 g of AA (L-arginine and L-lysine), respectively. Mean serum levels of potassium and other parameters (glomerular filtration rate [GFR], creatinine, blood urea nitrogen [BUN], phosphate, chloride, lactate dehydrogenase) prior to, 4 h and 24 h after AA infusion were compared. Results Self-limiting hyperkalaemia (>5.0 mmol/l) resolving after 24 h occurred in 91% (20/22) of patients in both protocols. Potassium levels, BUN, creatinine, GFR, phosphate, chloride and LDH showed a similar range at 4 h after co-infusion of 75 or 50 g of AA, respectively (p > 0.05). Only GFR and creatinine levels at 24 h varied significantly between the two co-infusion protocols (p < 0.05). Conclusions Hyperkalaemia is a frequent side effect of AA infusion in PRRT. Varying the dose of co-infused amino acids did not impact on the incidence and severity of hyperkalaemia.…
Author: | Rudolf A. Werner, Constantin Lapa, Christina Bluemel, Katharina Lückerath, Andreas Schirbel, Alexander Strate, Andreas K. Buck, Ken Herrmann |
---|---|
URN: | urn:nbn:de:bvb:20-opus-110617 |
Document Type: | Journal article |
Faculties: | Medizinische Fakultät / Institut für Klinische Biochemie und Pathobiochemie |
Medizinische Fakultät / Klinik und Poliklinik für Nuklearmedizin | |
Language: | English |
Year of Completion: | 2014 |
Source: | EJNMMI Research 2014, 4:46. doi:10.1186/s13550-014-0046-2 |
DOI: | https://doi.org/10.1186/s13550-014-0046-2 |
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
Tag: | Arginine; Hyperkalaemia; Lysine; NET; PRRT |
Release Date: | 2015/03/04 |
Collections: | Open-Access-Publikationsfonds / Förderzeitraum 2014 |
Licence (German): | CC BY: Creative-Commons-Lizenz: Namensnennung |